CLDX Celldex Therapeutics, Inc. - Common Stock
CLDX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
CLDX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
CLDX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 7 31.8%
- Buy 13 59.1%
- Hold 2 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
15 analysts · 2026-08-14Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.94 | $-1.08 | 0.14% |
| March 31, 2026 | $-1.18 | $-1.16 | -0.02% |
| Dec. 31, 2025 | $-1.22 | $-1.03 | -0.19% |
| Sept. 30, 2025 | $-1.01 | $-0.92 | -0.09% |
| June 30, 2025 | $-0.85 | $-0.87 | 0.02% |
| March 31, 2025 | $-0.81 | $-0.77 | -0.04% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Cost of Revenue | $200.0K | $200.0K | $300.0K | $100.0K | $100.0K | $200.0K | $100.0K | $700.0K | $700.0K | $2M | · | · | |
| R&D Expense | $245M | $164M | $118M | $82M | $53M | $43M | $43M | $66M | $96M | $103M | $100M | $104M | |
| SG&A Expense | $44M | $39M | $31M | $27M | $20M | $14M | $15M | $19M | $25M | $36M | $34M | $21M | |
| Operating Expenses | $289M | $202M | $161M | $118M | $76M | $71M | $59M | $166M | $134M | $140M | $135M | $126M | |
| Operating Income | $-287M | $-195M | $-155M | $-115M | $-71M | $-63M | $-55M | $-156M | $-122M | $-133M | $-130M | $-122M | |
| Pretax Income | $-259M | $-158M | $-141M | $-112M | $-71M | $-61M | $-51M | $-152M | $-117M | $-129M | $-127M | · | |
| Income Tax | $0 | $0 | $0 | · | $-227.0K | $-1M | · | $-765.0K | $-24M | · | · | · | |
| Net Income | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| EPS (Basic) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| EPS (Diluted) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| Shares (Basic) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| Shares (Diluted) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| EBITDA | $-284M | $-192M | $-152M | $-112M | $-68M | $-59M | $-50M | $-153M | $-117M | $-130M | $-127M | $-120M |
Balance Sheet 24
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $28M | $35M | $29M | $39M | $44M | $11M | $24M | $40M | $42M | $72M | $28M | |
| Short-term Investments | $490M | $697M | $389M | $276M | $369M | $151M | $53M | $70M | · | · | · | · | |
| Prepaid Expense | $14M | $21M | $5M | $12M | $2M | $2M | $1M | $2M | $3M | $4M | $4M | $4M | |
| Current Assets | $535M | $747M | $432M | $318M | $411M | $198M | $67M | $99M | $145M | $196M | $295M | $205M | |
| PP&E (Net) | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $6M | $10M | $13M | $11M | $11M | |
| PP&E (Gross) | $29M | $28M | $26M | $25M | $25M | $25M | $32M | $32M | $34M | $33M | $29M | $25M | |
| Accum. Depreciation | $24M | $23M | $22M | $22M | $21M | $21M | $28M | $26M | $24M | $20M | $17M | $14M | |
| Goodwill | · | · | · | · | · | · | · | · | $91M | $91M | $9M | $9M | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $31M | $49M | $49M | $68M | $81M | $21M | $22M | |
| Other Non-current Assets | $13M | $10M | $107.0K | $104.0K | $104.0K | $41.0K | $41.0K | $2M | $2M | $2M | $1M | $2M | |
| Total Assets | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Accounts Payable | $1M | $3M | $3M | $3M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $47M | $34M | $22M | $13M | $12M | $8M | $6M | $7M | $19M | $29M | $24M | $19M | |
| Current Liabilities | $51M | $40M | $31M | $19M | $17M | $14M | $12M | $13M | $28M | $35M | $30M | $24M | |
| Capital Leases | $784.0K | $2M | $928.0K | $3M | $1M | $2M | $2M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Other Non-current Liabilities | $4M | $3M | $4M | $5M | $7M | $10M | $16M | $19M | $52M | $83M | $17M | $12M | |
| Total Liabilities | $56M | $45M | $36M | $27M | $25M | $26M | $29M | $32M | $79M | $118M | $47M | $36M | |
| Common Stock | $67.0K | $66.0K | $56.0K | $47.0K | $47.0K | $40.0K | $17.0K | $12.0K | $9.0K | $121.0K | $99.0K | $90.0K | |
| Retained Earnings | $-1.81B | $-1.56B | $-1.40B | $-1.26B | $-1.14B | $-1.07B | $-1.01B | $-962M | $-813M | $-719M | $-591M | $-464M | |
| AOCI | $4M | $3M | $3M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stockholders' Equity | $527M | $747M | $429M | $326M | $419M | $209M | $94M | $124M | $236M | $265M | $290M | $212M | |
| Liabilities + Equity | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Shares Outstanding | 66,549,442 | 66,374,549 | 55,883,377 | 47,200,695 | 46,730,198 | 39,603,771 | 16,972,077 | 11,957,635 | 9,234,693 | 120,516,654 | 98,685,595 | 89,592,779 |
Cash Flow 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Stock-based Comp | $36M | $34M | $24M | $16M | $9M | $4M | $5M | $8M | $12M | $15M | $13M | $7M | |
| Amort. of Intangibles | · | · | · | · | · | $0 | $0 | $224.0K | $896.0K | $997.0K | $1M | $1M | |
| Other Non-cash | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-211M | $-158M | $-107M | $-104M | $-61M | $-40M | $-46M | $-75M | $-100M | $-113M | $-99M | $-102M | |
| CapEx | $3M | $2M | $2M | $2M | $1M | $2M | $731.0K | $813.0K | $2M | $3M | $5M | $2M | |
| Investing Cash Flow | $209M | $-290M | $-106M | $90M | $-216M | $-98M | $17M | $30M | $46M | $69M | $-50M | · | |
| Stock Issued | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Net Stock Activity | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Financing Cash Flow | $2M | $441M | $218M | $4M | $272M | $171M | $16M | $29M | $51M | $14M | $193M | · | |
| Net Change in Cash | $515.0K | $-6M | $5M | $-10M | $-5M | $33M | $-13M | $-16M | $-2M | $-30M | $44M | $-141M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-214M | $-160M | $-109M | $-106M | $-62M | $-42M | $-47M | $-76M | $-102M | $-116M | $-104M | $-103M |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% | -854.1% | -1540.2% | · | -953.7% | -1958.7% | -2363.9% | -3414.1% | |
| Net Margin | -16748.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -16748.0% | -2248.8% | -2054.8% | -4765.6% | -1520.9% | -821.6% | -1424.0% | · | -920.6% | · | · | · | |
| EBITDA Margin | -18381.0% | -2733.6% | -2201.6% | -4766.1% | -1465.8% | -801.1% | -1404.2% | · | -919.0% | -1913.1% | -2309.2% | -3347.5% | |
| ROA | -37.6% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -43.8% | · | · | · | · | · | · | · | · | · | · | · | |
| ROIC | -54.5% | · | · | · | -16.9% | -29.7% | · | -125.5% | -40.8% | · | · | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 | 13.9 | 5.7 | 7.9 | 5.2 | 5.6 | 9.8 | 8.4 | |
| Quick Ratio | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 | 13.7 | 5.5 | 1.9 | 1.5 | 1.2 | 2.4 | 1.1 |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -78.0% | 2.0% | 192.0% | -49.3% | -37.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -13.1% | 14.7% | -2.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -26.9% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Net Income TTM | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| Market Cap | $1.81B | $1.68B | $2.22B | $2.10B | $1.81B | $694M | $38M | $36M | $5.90B | $6.40B | $23.21B | $24.53B | |
| P/E | -7.0 | -10.3 | -13.6 | -18.6 | -23.6 | -8.7 | -0.6 | · | · | · | · | · | |
| P/S | 1169.9 | 238.9 | 322.0 | 892.5 | 388.2 | 93.5 | 10.6 | 3.8 | 463.1 | 943.0 | 4235.6 | 6839.4 | |
| P/B | 3.4 | 2.2 | 5.2 | 6.4 | 4.3 | 3.3 | 0.4 | 0.3 | 25.0 | 24.1 | 80.0 | 115.9 | |
| P / Tangible Book | 3.6 | 2.3 | 5.5 | 7.0 | 4.6 | 3.9 | · | · | · | · | · | · | |
| P / Cash Flow | -8.6 | -10.6 | -20.7 | -20.3 | -29.6 | -17.2 | -0.8 | -0.5 | -59.1 | -56.6 | -234.7 | -241.5 | |
| P / FCF | -8.5 | -10.5 | -20.3 | -19.9 | -29.0 | -16.5 | -0.8 | -0.5 | -58.0 | -55.3 | -223.7 | -237.0 | |
| Earnings Yield | -14.4% | -9.7% | -7.4% | -5.4% | -4.2% | -11.5% | -157.4% | · | · | · | · | · |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.0K | $15.0K | $121.0K | $0 | $730.0K | $695.0K | $1M | $3M | $2M | $156.0K | $2M | $268.0K | $967.0K | $2M | $407.0K | $163.0K | |
| R&D Expense | $68M | $73M | $75M | $63M | $54M | $53M | $47M | $45M | $40M | $32M | $35M | $26M | $27M | $23M | $22M | $21M | |
| SG&A Expense | $13M | $11M | $12M | $11M | $10M | $11M | $10M | $10M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Operating Expenses | $81M | $84M | $87M | $74M | $65M | $63M | $57M | $55M | $49M | $41M | $43M | $33M | $33M | $29M | $28M | $37M | |
| Operating Income | $-81M | $-84M | $-87M | $-74M | $-64M | $-63M | $-56M | $-52M | $-46M | $-41M | $-41M | $-33M | $-32M | $-28M | $-28M | $-36M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M | $-27M | $-36M | |
| Net Income | $-74M | $-79M | $-81M | $-67M | $-57M | $-54M | $-47M | $-42M | $-36M | $-33M | · | · | · | · | · | · | |
| EPS (Basic) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.57 | $-0.77 | |
| EPS (Diluted) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.57 | $-0.77 | |
| Shares (Basic) | 77,840,000 | 66,566,000 | 66,222,805 | 66,420 | 66,392,000 | 66,383,000 | 64,203,816 | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | -93,526 | 46,916 | 46,759 | |
| Shares (Diluted) | 77,840,000 | 66,566,000 | 66,222,805 | 66,420 | 66,392,000 | 66,383,000 | 64,203,816 | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | -93,526 | 46,916 | 46,759 | |
| EBITDA | $-81M | · | · | $-74M | $-64M | $-62M | · | $-52M | $-46M | $-40M | $-41M | $-33M | $-32M | · | $-28M | $-36M |
Balance Sheet 22
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $36M | $29M | $36M | $23M | $17M | $28M | $36M | $43M | $115M | $21M | $28M | $54M | · | $19M | $28M | |
| Short-term Investments | $670M | $416M | $490M | $547M | $607M | $656M | $697M | $720M | $760M | $709M | $214M | $224M | $224M | · | $305M | $328M | |
| Prepaid Expense | $7M | $8M | $14M | $21M | $18M | $19M | $21M | $22M | $8M | $9M | $10M | $12M | $10M | · | $11M | $11M | |
| Current Assets | $725M | $459M | $535M | $604M | $648M | $694M | $747M | $779M | $812M | $835M | $246M | $265M | $290M | · | $335M | $368M | |
| PP&E (Net) | $10M | $7M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | |
| PP&E (Gross) | · | · | $29M | · | · | · | $28M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $24M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | $27M | $27M | |
| Other Non-current Assets | $15M | $15M | $13M | $9M | $9M | $10M | $10M | $10M | $107.0K | $107.0K | $107.0K | $107.0K | $104.0K | · | $104.0K | $104.0K | |
| Total Assets | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | · | $369M | $403M | |
| Accounts Payable | $15M | $10M | $1M | $4M | $2M | $3M | $3M | $1M | $4M | $3M | $4M | $881.0K | $3M | · | $2M | $902.0K | |
| Accrued Liabilities | $44M | $38M | $47M | $40M | $28M | $25M | $34M | $28M | $19M | $18M | $18M | $12M | $9M | · | $11M | $11M | |
| Current Liabilities | $61M | $51M | $51M | $46M | $33M | $32M | $40M | $32M | $28M | $26M | $28M | $16M | $15M | · | $16M | $30M | |
| Capital Leases | $3M | $443.0K | $784.0K | $1M | $1M | $2M | $2M | $2M | $796.0K | $470.0K | $1M | $2M | $2M | · | $2M | $3M | |
| Other Non-current Liabilities | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | · | $5M | $5M | |
| Total Liabilities | $68M | $55M | $56M | $50M | $37M | $36M | $45M | $37M | $32M | $30M | $34M | $22M | $22M | · | $24M | $38M | |
| Common Stock | $79.0K | $67.0K | $67.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $47.0K | $47.0K | $47.0K | · | $47.0K | $47.0K | |
| Retained Earnings | $-1.97B | $-1.89B | $-1.81B | $-1.73B | $-1.67B | $-1.61B | $-1.56B | $-1.51B | $-1.47B | $-1.43B | $-1.35B | $-1.32B | $-1.29B | · | $-1.23B | $-1.20B | |
| AOCI | $1M | $3M | $4M | $4M | $3M | $4M | $3M | $5M | $2M | $2M | $2M | $2M | $2M | · | $-112.0K | $-417.0K | |
| Stockholders' Equity | $715M | $456M | $527M | $598M | $655M | $703M | $747M | $786M | $814M | $839M | $247M | $278M | $303M | $326M | $345M | $365M | |
| Liabilities + Equity | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | · | $369M | $403M | |
| Shares Outstanding | 78,500,173 | 66,568,971 | 66,549,442 | 66,446,846 | 66,394,241 | 66,384,191 | 66,374,549 | 66,344,236 | 66,280,667 | 65,910,548 | 47,264,197 | 47,253,813 | 47,244,681 | · | 47,096,063 | 46,764,703 |
Cash Flow 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $902.0K | $854.0K | $816.0K | $824.0K | $873.0K | $867.0K | $819.0K | $786.0K | $797.0K | $775.0K | $767.0K | $756.0K | $726.0K | $673.0K | $671.0K | $741.0K | |
| Stock-based Comp | $8M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $8M | $7M | $7M | $5M | $4M | $5M | $4M | $3M | |
| Operating Cash Flow | $-57M | $-66M | $-64M | $-49M | $-44M | $-54M | $-32M | $-55M | $-29M | $-41M | $-19M | $-27M | $-29M | $-22M | $-35M | $-22M | |
| CapEx | $3M | $2M | $1M | $440.0K | $728.0K | $265.0K | $756.0K | $545.0K | $274.0K | $344.0K | $157.0K | $410.0K | $585.0K | $235.0K | $345.0K | $673.0K | |
| Investing Cash Flow | $-256M | $72M | $55M | $61M | $50M | $43M | $24M | $48M | $-47M | $-315M | $12M | $1M | $53M | $31M | $23M | $25M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $432M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $432M | · | · | · | · | · | · | |
| Financing Cash Flow | $325M | $327.0K | $1M | $774.0K | $63.0K | $202.0K | $386.0K | $1M | $4M | $436M | $257.0K | $133.0K | $694.0K | $1M | $2M | $71.0K | |
| Net Change in Cash | $12M | $7M | $-7M | $13M | $6M | $-11M | $-8M | $-6M | $-72M | $80M | $-7M | $-26M | $25M | $11M | $-10M | $3M | |
| Free Cash Flow | · | · | · | · | · | $-55M | · | · | · | $-41M | · | · | $-29M | · | · | · |
Profitability 6
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -366468.2% | · | · | · | -8747.5% | -9027.2% | · | -1633.5% | -1854.2% | -26030.8% | -2718.5% | -12389.9% | -3357.9% | · | -6804.9% | -22328.8% | |
| Net Margin | -334104.6% | · | · | · | -7753.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -6580.8% | -22088.3% | |
| EBITDA Margin | -366468.2% | · | · | · | -8747.5% | -8902.5% | · | -1633.5% | -1854.2% | -25534.0% | -2718.5% | -12389.9% | -3282.8% | · | -6804.9% | -22328.8% | |
| ROA | -10.0% | · | · | -9.1% | -7.4% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -10.7% | · | · | -9.7% | -7.7% | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | · | · | 13.0 | 19.7 | 21.7 | · | 24.3 | 29.4 | 31.8 | 8.8 | 16.9 | 19.0 | · | 20.5 | 12.3 | |
| Quick Ratio | 11.7 | · | · | 12.6 | 19.1 | 21.0 | · | 23.6 | 29.0 | 31.3 | 8.5 | 16.2 | 18.3 | · | 19.9 | 11.9 |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $7M | $7M | $7M | · | $7M | $4M | $3M | $3M | $2M | $2M | · | $897.0K | $4M | |
| Net Income TTM | $-276M | $-256M | · | $-220M | $-188M | $-165M | · | · | · | · | · | · | · | · | · | · | |
| Market Cap | $2.92B | · | · | $1.72B | $1.35B | $1.20B | · | $2.26B | $2.45B | $2.77B | $1.30B | $1.60B | $1.70B | · | $1.32B | $1.26B | |
| P/E | -9.3 | -8.2 | · | -7.8 | -7.2 | -7.1 | · | -13.3 | -14.5 | -15.9 | -10.4 | -13.0 | -14.7 | · | -12.3 | -13.2 | |
| P/S | · | · | · | 241.6 | 189.9 | 184.2 | · | 306.3 | 552.6 | 951.3 | 411.7 | 888.3 | 993.5 | · | 1475.9 | 317.6 | |
| P/B | 4.1 | · | · | 2.9 | 2.1 | 1.7 | · | 2.9 | 3.0 | 3.3 | 5.3 | 5.8 | 5.6 | · | 3.8 | 3.5 | |
| P / Tangible Book | 4.2 | 4.9 | · | 3.0 | 2.2 | 1.8 | · | 3.0 | 3.1 | 3.4 | 5.9 | 6.4 | 6.2 | · | 4.2 | 3.7 | |
| P / Cash Flow | · | · | · | · | · | -22.2 | · | · | · | -68.1 | · | · | -59.5 | · | · | · | |
| P / FCF | · | · | · | · | · | -22.1 | · | · | · | -67.5 | · | · | -58.3 | · | · | · | |
| Earnings Yield | -10.7% | -12.1% | · | -12.8% | -14.0% | -14.1% | · | -7.5% | -6.9% | -6.3% | -9.6% | -7.7% | -6.8% | · | -8.1% | -7.6% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $2M | $7M | $7M | $2M | $5M |
| Operating Margin % | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% |
| Net Income | $-259M | $-158M | $-141M | — | — |
| Diluted EPS | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 |
| Quick Ratio | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-214M | $-160M | $-109M | $-106M | $-62M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 278 filers · $2.6B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 62 (+2 vs prior Q) | 20 (+7 vs prior Q) | 99 (+31 vs prior Q) | 56 (+1 vs prior Q) | +15.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | $312,415,309 | 8,396,004 | 12.07% | Shares |
| Kynam Capital Management, LP | $198,065,407 | 5,322,908 | 7.65% | Shares |
| STATE STREET CORP | $145,134,889 | 3,900,427 | 5.61% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $128,926,362 | 3,464,831 | 4.98% | Shares |
| Deep Track Capital, LP | $109,365,809 | 2,939,151 | 4.22% | Shares |
| VANGUARD GROUP INC | $95,540,813 | 3,517,703 | 3.69% | Shares |
| FMR LLC | $87,111,215 | 2,341,070 | 3.36% | Shares |
| Logos Global Management LP | $78,141,000 | 2,100,000 | 3.02% | Shares |
| Eversept Partners, LP | $66,454,865 | 1,785,941 | 2.57% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $64,373,504 | 1,729,584 | 2.49% | Shares |
| Commodore Capital LP | $50,233,500 | 1,350,000 | 1.94% | Shares |
| Bellevue Group AG | $44,652,000 | 1,200,000 | 1.72% | Shares |
| BAKER BROS. ADVISORS LP | $44,004,955 | 1,182,611 | 1.70% | Shares |
| MILLENNIUM MANAGEMENT LLC | $43,564,984 | 1,170,787 | 1.68% | Shares |
| AMERICAN CENTURY COMPANIES INC | $38,787,594 | 1,042,395 | 1.50% | Shares |
| EVENTIDE ASSET MANAGEMENT, LLC | $38,586,770 | 1,037,000 | 1.49% | Shares |
| NOVO HOLDINGS A/S | $38,140,250 | 1,025,000 | 1.47% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $37,326,505 | 1,003,131 | 1.44% | Shares |
| Elmind Capital, LP | $36,837,900 | 990,000 | 1.42% | Shares |
| Driehaus Capital Management LLC | $36,817,137 | 989,442 | 1.42% | Shares |
| Fisher Asset Management, LLC | $36,677,040 | 985,677 | 1.42% | Shares |
| Pictet Asset Management Holding SA | $34,136,752 | 917,408 | 1.32% | Shares |
| Foresite Capital Management VI LLC | $32,734,121 | 879,713 | 1.26% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $32,132,175 | 863,536 | 1.24% | Shares |
| GOLDMAN SACHS GROUP INC | $31,451,827 | 845,252 | 1.21% | Shares |
| Assenagon Asset Management S.A. | $29,347,378 | 788,696 | 1.13% | Shares |
| Woodline Partners LP | $26,077,884 | 700,830 | 1.01% | Shares |
| Affinity Asset Advisors, LLC | $26,047,000 | 700,000 | 1.01% | Shares |
| Rock Springs Capital Management LP | $26,015,223 | 699,146 | 1.00% | Shares |
| TWO SIGMA INVESTMENTS, LP | $24,604,554 | 661,235 | 0.95% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24,408,048 | 655,954 | 0.94% | Shares |
| ALGERT GLOBAL LLC | $24,105,978 | 647,836 | 0.93% | Shares |
| ADAR1 Capital Management, LLC | $23,053,158 | 619,542 | 0.89% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $21,304,139 | 572,538 | 0.82% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $20,576,125 | 552,973 | 0.79% | Shares |
| 5AM Venture Management, LLC | $18,503,417 | 497,270 | 0.71% | Shares |
| FEDERATED HERMES, INC. | $18,340,549 | 492,893 | 0.71% | Shares |
| Candriam S.C.A. | $17,885,437 | 481,125 | 0.69% | Shares |
| Ikarian Capital, LLC | $17,804,985 | 478,500 | 0.69% | Shares |
| BRAIDWELL LP | $16,247,598 | 436,646 | 0.63% | Shares |
| Redmile Group, LLC | $16,146,200 | 433,921 | 0.62% | Shares |
| CITIGROUP INC | $14,891,144 | 400,192 | 0.58% | Shares |
| Palo Alto Investors LP | $14,878,642 | 399,856 | 0.57% | Shares |
| TSP Capital Management Group, LLC | $13,809,638 | 371,127 | 0.53% | Shares |
| PFM Health Sciences, LP | $12,753,765 | 342,751 | 0.49% | Shares |
| KENNEDY CAPITAL MANAGEMENT LLC | $12,738,025 | 342,328 | 0.49% | Shares |
| SEGALL BRYANT & HAMILL, LLC | $12,513,388 | 336,291 | 0.48% | Shares |
| Tetragon Partners GP Ltd | $10,807,310 | 290,441 | 0.42% | Shares |
| SUPERSTRING CAPITAL MANAGEMENT LP | $10,700,963 | 287,583 | 0.41% | Shares |
| GordonMD Global Investments LP | $10,408,381 | 279,720 | 0.40% | Shares |
| BANK OF AMERICA CORP /DE/ | $9,518,951 | 255,817 | 0.37% | Shares |
| SummitTX Capital, L.P. | $9,487,024 | 254,959 | 0.37% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $8,962,698 | 240,868 | 0.35% | Shares |
| Rosalind Advisors, Inc. | $7,442,000 | 200,000 | 0.29% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $7,285,273 | 195,788 | 0.28% | Shares |
| Corient Private Wealth LP | $6,925,155 | 186,110 | 0.27% | Shares |
| Trexquant Investment LP | $6,866,138 | 184,524 | 0.27% | Shares |
| Mirador Capital Partners LP | $6,737,019 | 181,054 | 0.26% | Shares |
| STEMPOINT CAPITAL LP | $6,638,711 | 178,412 | 0.26% | Shares |
| BlackRock, Inc. | $6,469,963 | 173,877 | 0.25% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,422,446 | 172,600 | 0.25% | Call option |
| Cinctive Capital Management LP | $5,419,153 | 145,637 | 0.21% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $5,211,781 | 140,064 | 0.20% | Shares |
| FIRST TRUST ADVISORS LP | $5,160,357 | 138,682 | 0.20% | Shares |
| Swiss National Bank | $5,023,350 | 135,000 | 0.19% | Shares |
| MONTANOVA CAPITAL, LLC | $4,513,461 | 121,297 | 0.17% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $4,481,126 | 120,428 | 0.17% | Shares |
| Point72 Asset Management, L.P. | $4,361,645 | 117,217 | 0.17% | Shares |
| Ikarian Capital, LLC | $4,241,940 | 114,000 | 0.16% | Put option |
| RHUMBLINE ADVISERS | $3,905,662 | 104,963 | 0.15% | Shares |
| Propel Bio Management, LLC | $3,858,491 | 103,695 | 0.15% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,754,489 | 100,900 | 0.15% | Put option |
| Integral Health Asset Management, LLC | $3,721,000 | 100,000 | 0.14% | Shares |
| DEUTSCHE BANK AG\ | $3,601,705 | 96,794 | 0.14% | Shares |
| Odyssean, LLC | $3,537,517 | 95,069 | 0.14% | Shares |
| Caption Management, LLC | $3,348,900 | 90,000 | 0.13% | Put option |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3,324,267 | 89,338 | 0.13% | Shares |
| HighVista Strategies LLC | $3,235,930 | 86,964 | 0.12% | Shares |
| DIADEMA PARTNERS LP | $3,200,060 | 86,000 | 0.12% | Put option |
| AXA Investment Managers S.A. | $3,138,704 | 121,326 | 0.12% | Shares |
| Bank of New York Mellon Corp | $3,020,782 | 81,182 | 0.12% | Shares |
| PDT Partners, LLC | $3,010,252 | 80,899 | 0.12% | Shares |
| TD Asset Management Inc | $2,951,720 | 79,326 | 0.11% | Shares |
| ALPS ADVISORS INC | $2,945,730 | 79,165 | 0.11% | Shares |
| ALLIANCEBERNSTEIN L.P. | $2,811,661 | 88,640 | 0.11% | Shares |
| XTX Topco Ltd | $2,795,773 | 75,135 | 0.11% | Shares |
| Seven Fleet Capital Management LP | $2,610,802 | 70,164 | 0.10% | Shares |
| Birchview Capital, LP | $2,600,979 | 69,900 | 0.10% | Shares |
| Quantinno Capital Management LP | $2,569,276 | 69,048 | 0.10% | Shares |
| DAFNA Capital Management LLC | $2,549,555 | 68,518 | 0.10% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2,525,864 | 79,630 | 0.10% | Shares |
| Man Group plc | $2,362,984 | 63,504 | 0.09% | Shares |
| Rafferty Asset Management, LLC | $2,089,602 | 56,157 | 0.08% | Shares |
| Caption Management, LLC | $2,072,597 | 55,700 | 0.08% | Shares |
| Simplify Asset Management Inc. | $1,977,116 | 53,134 | 0.08% | Shares |
| DIADEMA PARTNERS LP | $1,893,989 | 50,900 | 0.07% | Call option |
| Burkehill Global Management, LP | $1,860,500 | 50,000 | 0.07% | Shares |
| SEVEN GRAND MANAGERS, LLC | $1,860,500 | 50,000 | 0.07% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $1,850,491 | 49,731 | 0.07% | Shares |
| MetLife Investment Management, LLC | $1,694,060 | 45,527 | 0.07% | Shares |
Company insiders 49 insiders · 19 officers · 23 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Anthony S Marucci | PRESIDENT & CEO | June 25, 2026 A | 27,231 | 0 | 0 | $0 |
| Una S Ryan | President & CEO | March 7, 2008 A | 899,213 | 0 | 0 | $0 |
| Samuel Bates Martin | SVP AND CFO | June 25, 2026 A | 24,378 | 0 | 0 | $0 |
| Avery W Catlin | Sr. VP & CFO | Sept. 2, 2016 M | 83,586 | 0 | 0 | $0 |
| Teri L Lawver | SVP & Chief Commercial Officer | June 25, 2026 A | — | 0 | 0 | $0 |
| Freddy A. Jimenez | SVP & GENERAL COUNSEL | June 25, 2026 A | 430 | 0 | 0 | $0 |
| Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | June 25, 2026 A | 11,247 | 0 | 0 | $0 |
| Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | June 25, 2026 A | 408 | 0 | 0 | $0 |
| Elizabeth Crowley | SR. VP & CPDO | June 25, 2026 A | 4,726 | 0 | 0 | $0 |
| Diane C. Young | SVP, CHIEF MEDICAL OFFICER | June 25, 2026 A | 2,115 | 0 | 0 | $0 |
| Tibor Keler | EXECUTIVE VP & CSO | June 25, 2026 A | 7,357 | 0 | 0 | $0 |
| Ronald Pepin | SR. VP & CBO | June 25, 2026 A | 20,097 | 0 | 0 | $0 |
| Richard M. Wright | Sr. VP & CCO | June 17, 2021 A | 208 | 0 | 0 | $0 |
| Theresa Lavallee | SVP, Reg.& Precision Medicine | Dec. 14, 2016 A | — | 0 | 0 | $0 |
| Ronald C Newbold | Sr. VP, Business Dev. | Jan. 6, 2009 A | 5,868 | 0 | 0 | $0 |
| Henry C Marsh JR | V.P. Research | March 7, 2008 M | — | 0 | 0 | $0 |
| Ronald W Ellis | Sr VP R&D | Jan. 5, 2007 A | — | 0 | 0 | $0 |
| Michael E Furlong | Sr. Dir. Bus. Development | July 1, 2005 L | 1,500 | 0 | 0 | $0 |
| Alistair Wheeler | V.P. Medical Affairs | Jan. 2, 2004 A | — | 0 | 0 | $0 |
| Denice Torres | Director | June 25, 2026 A | — | 0 | 0 | $0 |
| Rita Jain | Director | June 25, 2026 A | — | 0 | 0 | $0 |
| Garry Arthur Neil | Director | June 25, 2026 A | — | 0 | 0 | $0 |
| Cheryl Cohen | Director | June 25, 2026 A | — | 0 | 0 | $0 |
| Keith L Brownlie | Director | June 25, 2026 A | 10,000 | 0 | 0 | $0 |
| Herbert J Conrad | Director | June 25, 2026 A | 38,500 | 0 | 0 | $0 |
| James J Marino | Director | June 25, 2026 A | 12,704 | 0 | 0 | $0 |
| Harry Penner JR | Director | June 25, 2026 A | 41,916 | 0 | 0 | $0 |
| Karen Shoos Lipton | Director | June 17, 2021 A | 41,833 | 0 | 0 | $0 |
| Gerald Mcmahon PhD | Director | Dec. 3, 2018 F | 180,697 | 0 | 0 | $0 |
| Larry Ellberger | Director | June 13, 2018 A | 73,500 | 0 | 0 | $0 |
| Richard Van Den Broek | Director | June 8, 2016 A | 233,500 | 0 | 0 | $0 |
| Timothy M Shannon | Director | June 4, 2014 A | 83,212 | 0 | 0 | $0 |
| Rajesh R Parekh | Director | Sept. 22, 2010 A | 2,000 | 0 | 0 | $0 |
| Charles R Schaller | Director | Sept. 9, 2010 P | 5,000 | 0 | 0 | $0 |
| Alf A Lindberg | Director | May 24, 2007 A | — | 0 | 0 | $0 |
| Francis R Cano | Director | May 24, 2007 A | — | 0 | 0 | $0 |
| Peter A Sears | Director | May 24, 2007 A | 72,739 | 0 | 0 | $0 |
| Barrie J Ward | Director | May 25, 2006 A | 367,915 | 0 | 0 | $0 |
| PDI INC | Director | May 26, 2005 A | — | 0 | 0 | $0 |
| Frederick W Kyle | Director | May 13, 2004 C | 7,000 | 0 | 0 | $0 |
| MEDAREX INC | 10% owner | June 24, 2009 S | 2,960,848 | 0 | 0 | $0 |
| Lorantis Holdings LTD | 10% owner | April 7, 2008 J | 0 | 0 | 0 | $0 |
| Thomas Andrew Davis | — | June 15, 2017 A | 1,011 | 0 | 0 | $0 |
| George Elston | — | June 8, 2016 A | 28,500 | 0 | 0 | $0 |
| Taha Keilani | — | March 7, 2008 A | 2,000 | 0 | 0 | $0 |
| Paula R Freeman | — | March 7, 2008 M | 2,955 | 0 | 0 | $0 |
| Michael Timothy Cooke | — | Jan. 5, 2007 A | — | 0 | 0 | $0 |
| Mary Nicholson | — | Jan. 3, 2005 A | 500 | 0 | 0 | $0 |
| Anthony Helstosky | — | Jan. 6, 2004 C | 6,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Medarex, Inc. I.R.S. Employer Identification Number ×3 filings | June 26, 2009 | — | Initial filing | — | SEC |
| Lorantis Holdings Limited ×2 filings | May 12, 2008 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 50 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 1.33% | 68,615 NS | May 31, 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0.88% | 10,032 NS | April 30, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.44% | 70,017 NS | April 30, 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0.23% | 3,856 NS | May 31, 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.23% | 73,629 NS | April 30, 2026 | N-PORT |
| IWO · iShares Trust | 0.16% | 576,359 SH | Aug. 8, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.16% | 62,064 NS | April 30, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.14% | 67,853 SH | Aug. 8, 2026 | Daily |
| FFSM · FIDELITY COVINGTON TRUST | 0.13% | 51,835 NS | April 30, 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.12% | 43,658 NS | April 30, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.12% | 8,106 SH | Aug. 8, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.11% | 24,795 NS | April 30, 2026 | N-PORT |
| IWM · iShares Trust | 0.10% | 1,997,393 SH | Aug. 8, 2026 | Daily |
| SMMV · iShares Trust | 0.09% | 6,577 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.09% | 449,534 SH | Aug. 8, 2026 | Daily |
| ISCV · iShares Trust | 0.08% | 14,142 SH | Aug. 8, 2026 | Daily |
| RSSL · Global X Funds | 0.08% | 32,806 NS | April 30, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.07% | 51,058 SH | Aug. 8, 2026 | Daily |
| ESML · iShares Trust | 0.06% | 44,111 SH | Aug. 8, 2026 | Daily |
| ITWO · ProShares Trust | 0.06% | 3,561 NS | May 31, 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 368,761 NS | May 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.05% | 204,021 NS | April 30, 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.05% | 6,865 NS | April 30, 2026 | N-PORT |
| ISCB · iShares Trust | 0.04% | 2,846 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.04% | 12,901 SH | Aug. 8, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.04% | 201,834 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.04% | 137,013 SH | Aug. 8, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 30,973 NS | April 30, 2026 | N-PORT |
| UWM · ProShares Trust | 0.04% | 2,786 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 897,276 SH | Aug. 8, 2026 | Daily |
| WSML · iShares Trust | 0.03% | 4,615 SH | Aug. 8, 2026 | Daily |
| URTY · ProShares Trust | 0.03% | 2,818 NS | May 31, 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 6,539 NS | May 31, 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 2,668 NS | May 31, 2026 | N-PORT |
| HDG · ProShares Trust | 0.01% | 71 NS | May 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 7,780 NS | April 30, 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 26,307 NS | May 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 4,620 NS | April 30, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 753 NS | April 30, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 79,390 NS | April 30, 2026 | N-PORT |
| ITOT · iShares Trust | 0.01% | 117,267 SH | Aug. 8, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 22,367 SH | Aug. 8, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 15,559 NS | April 30, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 2,758 NS | April 30, 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 45,244 NS | May 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 14,544 NS | April 30, 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 500 NS | May 31, 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 636 NS | May 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,488,906 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,489 SH | Aug. 8, 2026 | Daily |